Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1350-1356

  Hepburn, Matthew J ^a   Little, Patrick J ^a   Gingras, Jeanine ^a   Kuhn, Cynthia M ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALTRINDOLE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MORPHINE ADDICTION; MORPHINE TOLERANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; RESPIRATION DEPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

ANIMALS; DRUG TOLERANCE; FEMALE; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE-RELATED DISORDERS;

EID: 0030960361     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. ABDELHAMMID, E. E., SULTANA, M., PORTOGHESE, P. S. AND TAKEMORI, A. E.: Selective blockade of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258: 299-303, 1991.
2. AYERS, E. A., DAVIS, P. AND BURKS, T. F.: In vivo and in vitro investigation of naltrindole, a δ-opioid antagonist. Proc. West. Pharmacol. Soc. 33: 55-63, 1990.
3. BIANCHETTI, A., GIUDICE, A., NAVA, F. AND MANARA, L.: Dissociation of morphine withdrawal diarrhea and jumping in mice by the peripherally selective opioid antagonist, SR 58002 C. Life Sci. 39: 2297-2303, 1986.
4. CALCAGNETTI, D. J. AND HOLTZMAN, S. G.: Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine. Pharmacol. Biochem. Behav. 38: 185-190, 1991.
5. CHANG, K. J., COOPER, B. R., HAZUM, E. AND CUATRECASAS, P.: Multiple opiate receptors: Different regional distribution in the brain and differential binding of opiates and opioid peptides. Mol. Pharmacol. 16: 91-104, 1979.
6. CRAFT, R. M., HENLEY, S. R., HAASETH, R. C., HRUBY, V. J. AND PORRECAM, F.: Opioid antinociception in a rat model of visceral pain: Systemic versus local drug administration. J. Pharmacol. Exp. Ther. 275: 1535-1542, 1995.
7. 5] enkephalin in the rat. J. Pharmacol. Exp. Ther. 259: 725-731, 1991.
8. EISENBERG, R. M.: DAMGO stimulates the hypothalamo-pituitary-adrenal axis through a mu-2 opioid receptor. J. Pharmacol. Exp. Ther. 266: 985-991, 1993.
9. FUNDYTUS, M. E., SCHILLER, P. W., SRAPIRO, M., WELTROWSKA, G. AND CODERRE, T. J.: Attenuation of morphine tolerance and dependence with the highly selective δ-opioid receptor antagonist TIPP [ψ]. Eur. J. Pharmacol. 286: 105-108, 1995.
10. 5] enkephalin. Eur. J. Pharmacol. 165: 1-10, 1989.
11. HURLE, M. A., MEDIAVILLA, A. AND FLORES, J.: Morphine, pentobarbital and naloxone in the ventral medullary chemosensitive areas: Differential respiratory and cardiovascular effects. J. Pharmacol. Exp. Ther. 220: 642-647, 1982.
12. HURLE, M. A., MEDIAVILLA, A. AND FLORES, J.: Differential respiratory patterns induced by opioids applied to the ventral medullary and dorsal pontine surfaces of cats. Neuropharmacology 24: 597-606, 1985.
13. 2] deltorphinll, a novel and highly selective delta-apioid receptor agonist. Peptides 13: 1123-1126, 1992.
14. JACKSON, H. C., RIPLEY, T. L. AND NUTT, D. J.: Exploring delta receptor function using the selective opioid antagonist naltrindole. Neuropharmacology 28: 1427-1430, 1989.
15. JANSSEN, P. A., NIEMEGEERS, C. J. AND DONY, J. G.: The inhibitory effect of fentanyl and other morphine-like analgesics on the warm-water induced tail withdrawal reflex in rats. Azneim. Forsch. 13: 502-507, 1963.
16. 6] enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257: 1069-1075, 1991.
17. KOOB, G. F., MALDONADO, R. AND STINUS, L.: Neural substrates of opiate withdrawal. TINS 15: 186-191, 1992.
18. LEE, P. H. K., MCNUTT, R. W. AND CHANG, K.: A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat. J. Pharmacol. Exp. Ther. 267: 883-887, 1993.
19. LING, G. S. F., SPIEGEL, K., LOCKMART, S. H. AND PASTERNAK, G. W.: Separation of opioid analgesia from respiratory depression: Evidence for different receptor mechanisms. J. Pharmacol. Exp. Ther. 232: 149-155, 1985.
20. MALDONADO, R., STINUS, L. AND KOOB, G. F.: Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261: 669-677, 1992.
21. MALMBERG, A. B. AND YAKSH, T. L.: Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: Effects of naltrindole and its benzofuran analog (NTB). J. Pharmacol. Exp. Ther. 263: 264-275, 1992.
22. MAYFIELD, K. P. AND D'ALECY, L. G.: Delta-1 opioid receptor dependence of acute hypoxic adaptations. J. Pharmacol. Exp. Ther. 268: 74-77, 1994a.
23. MAYFIELD, K. P. AND D'ALECY, L. G.: Delta-1 opioid agonist acutely increases hypoxic tolerance. J. Pharmacol. Exp. Ther. 268: 683-688, 1994b.
24. MIYAMOTO, Y., BOWEN, W. D., PORTOGHESE, P. S. AND TAKEMORI, A. E.: Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice. J. Pharmacol. Exp. Ther. 270: 37-39, 1994.
25. MIYAMOTO, Y., PORTOGHESE, P. S, AND TAKEMORI, A. E.: Involvement of delta-2 opioid receptors in acute dependence on morphine in mice. J. Pharmacol. Exp. Ther. 265: 1325-1327, 1993.
26. MORIN-SURUN, M. P., BOUDINOT, E., GACEL, G., CHAMPAGNAT, J., ROQUES, B. P. AND DENAVIT-SAUBIE, B.: Different effects of mu and delta opiate agonists on respiration. Eur. J. Pharmacol. 98: 235-240, 1984.
27. NEGUS, S. S., PASTERNAK, G. W., KOOB, G. F. AND WEINGER, M. B.: Antagonist effects of β-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat. J. Pharmacol. Exp. Ther. 264: 739-745, 1993.
28. PAZOS, A. AND FLOREZ, J.: A comparative study in rats of the respiratory depression and analgesia induced by mu and delta agonists. Eur. J. Pharmacol. 99: 15-21, 1984.
29. PASTERNAK, G. W.: Multiple mu opiate receptors: Biochemical and pharmacological evidence for multiplicity. Biochem. Pharmacol. 35: 361-364, 1986.
30. PORRECA, F., TAKEMORI, A. E., SULTANA, M., PORTOGHESE, P. S., BOWEN, W. D. AND MOSBERG, H. I.: Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J. Pharmacol. Exp. Ther. 263: 147-152. 1992.
31. PORTOGHESE, P. S., SULTANA, M. AND TAKEMORI, A. E.: Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur. J. Pharmacol. 146: 185-186, 1988.
32. ROERIG, S. C., FUJIMOTO, J. M. AND LANGE, D. G.: Development of tolerance to respiratory depression in morphine- and etorphine-pellet-implanted mice. Brain Res. 400: 278-284, 1987.
33. ROGERS, H., HAYES, A. G., BIRCH, P. J., TRAYNOR, J. R. AND LAWRENCE, A. J.: The selectivity of the opioid antagonist naltrindole for δ-opioid receptors. J. Pharm. Pharmacol. 42: 358-359, 1990.
34. ROSSI, G. C., PASTERNAK, G. W. AND BODNAR, R. J.: Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla. Brain Res. 665: 85-93, 1994.
35. ROTHMAN, R. B., LONG, J. B., BYKOV, V., JACOBSON, A. E., RICE, K. C. AND HOLIDAY, J. W.: β-FNA binds irreversibly to the opiate receptor complex: In vivo and in vitro evidence. J. Pharmacol. Exp. Ther. 247: 405-416, 1988.
36. SCHOFFELMEER, A. N., DEVRIES, T. J., HOGENBOMM, F. AND MULDER, A. H.: Mu and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a sensitivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors. J. Pharmacol. Exp. Ther. 267: 205-210, 1993.
37. 125I] b-endorphin to opioid receptors in rat striatal membranes: Biochemical evidence for the existence of a muldelta opioid receptor complex. J. Pharmacol. Exp. Ther. 253: 419-426, 1990.
38. SHOOK, J. E., WATKINS, W. D. AND CAMPORESI, E. M.: Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am. Rev. Respir. Dis. 142: 895-909, 1990.
39. SOFUOGLU, M., PORTOGHESE, P. S. AND TAKEMORI, A. E.: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257: 676-680, 1991.
40. TAYLOR, J. R., ELSWORT, J. D., GARCIA, E. J., GRANT, S. J., ROTH, R. H. AND REDMOND, D. E.: Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology 96: 121-134, 1988.
41. TAVIERA DA SILVA, A. M., SOUZA, J. D., QUEST, J. A., PAGANI, F. D., MOERSCHBAECHER, J. M., BULLER, A., HAMOSH, P. AND GILLIS, R. A.: Central nervous site for action for the respiratory depressant effect of diacetylmorphine (heroin) in the cat. J. Clin. Invest. 72: 1209-1217, 1983.
42. TRAYNOR, J. R. AND ELLIOT, J.: Delta-opioid receptor subtypes and cross-talk with mu-receptors. TIPS 14: 84-85, 1993.
43. WEESE-MAYER, D. E., KLEMKA-WALDEN, L. M., BARKOV, G. A. AND GINGRAS, J. L.: Effects of prenatal cocaine on the ventilatory response to hypoxia in newborn rats. Dev. Pharmacol. Ther. 18: 116-124, 1992.
44. WILD, K. D., MCCORMICK, J., BILSKY, E. J., VANDERAH, T., MCNUTT, R. W., CHANG, K-J. AND PORRECA, F.: Antinociceptive actions of BW373U86 in the mouse. J. Pharmacol. Exp. Ther. 267: 858-863, 1993.
45. WINDH, R. T., LIITLE, P. J. AND KUHN, C. M.: The ontogeny of mu opiate tolerance and dependence in the rat: Antinociceptive and biochemical studies. J. Pharmacol. Exp. Ther. 273: 1361-1374, 1995.
46. YAKSH, T. L., MALMBERG, A. B., Ro, S., SCHILLER, P. AND GOODMAN, M.: Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids. J. Pharmacol. Ther. Exp. 275: 63-72, 1995.
47. YOBURN, B. C., CHEN, J., HUANG, T. AND INTURRISI, C. E.: Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat. J. Pharmacol. Exp. Ther. 235: 282-286, 1985.